BCL2L11 and carcinoma: Various studies have identified that miR-192-5p has several target mRNAs, for example, p53 and a regulatory gene that targets the p53 signaling pathway, BIM, RB1, SEMA3A, therefore, it was suggested that it is a tumor suppressor in various malignant carcinomas [75].